NCT02373371 2025-07-29
Actinic Keratoses Treatment With Metvix® in Combination With Light
University Hospital, Limoges
Phase 3 Completed
Clinical Trials
14 trialsNCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT05725213 2024-02-23
ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
Galderma Laboratorium GmbH
Completed
NCT05522036 2023-10-18
Dermaris-35
Centre Dermatologique du Roy
Phase NA Completed
NCT01475071 2021-02-18
CoMet
Galderma R&D
Phase 3 Completed
NCT03511326 2021-02-18
SESAME 2
Galderma R&D
Phase 4 Completed
NCT02674048 2021-02-17
SESAME
Galderma R&D
Completed
NCT02464709 2019-08-28
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Joint Authority for Päijät-Häme Social and Health Care
Phase 4 Completed
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT02799069 2017-04-28
Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT03013647 2017-01-06
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
University of Sao Paulo General Hospital
Phase NA Unknown
NCT02149342 2016-07-11
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Completed
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed
NCT00711178 2010-11-02
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
Bispebjerg Hospital
Phase NA Completed